Early SGLT2 Inhibitor Therapy in Acute Coronary Syndrome: Mitigating Adverse Remodeling in High-Risk Phenotypes—A Real-World Study
<i>Background and Objectives:</i> SGLT2 inhibitors are foundational in heart failure therapy, yet their impact on left ventricular (LV) remodeling immediately following acute coronary syndrome (ACS) remains less defined. This study evaluated the association between early SGLT2 inhibitor initiation a...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2026-01-01
|
| Serie: | Medicina |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/1648-9144/62/1/205 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
